Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dapsone-induced sulfone syndrome.

Kimberly B Lee1, Trisha B Nashed

  • 1Antimicrobial Management Team, Department of Pharmacy, Virginia Commonwealth University Health System/Medical College of Virginia Hospitals and Physicians, Richmond, VA, USA. kblee@hsc.vcu.edu

The Annals of Pharmacotherapy
|July 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of technology and disparities in antimicrobial stewardship: a narrative review.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Collaboration on antimicrobial stewardship practices amongst university health systems, Veterans Affairs medical centers, and other affiliates: opportunities for greater harmony.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2023
Same author

Association between meeting core elements for inpatient antimicrobial stewardship and antibiotic utilization.

Infection control and hospital epidemiology·2019
Same author

The impact of formulary restriction on the relative consumption of carbapenems in intensive care units at an academic medical center.

Infection control and hospital epidemiology·2019
Same author

Rapid respiratory panel testing: Impact of active antimicrobial stewardship.

American journal of infection control·2018
Same author

Antimicrobial stewardship practices in Virginia.

American journal of infection control·2016

Dapsone can cause a rare but serious condition called sulfone syndrome, characterized by fever, rash, and liver injury. Promptly stopping dapsone treatment leads to symptom resolution.

Area of Science:

  • Pharmacology
  • Dermatology
  • Hepatology

Background:

  • Dapsone is a medication used for various conditions.
  • Sulfone syndrome is a rare adverse drug reaction.
  • Awareness of this syndrome is crucial for patient safety.

Observation:

  • A case of sulfone syndrome in an HIV-infected patient is presented.
  • Symptoms included fever, lymphadenopathy, exfoliative dermatitis, hepatitis, and methemoglobinemia.
  • These symptoms emerged four weeks after initiating dapsone therapy.

Findings:

  • Sulfone syndrome is not dose-dependent and typically occurs within two months of starting dapsone.
  • Common manifestations include fever, rash, and hepatic injury.
  • Cessation of dapsone led to complete symptom and laboratory abnormality resolution.

Related Experiment Videos

Implications:

  • Healthcare providers must recognize sulfone syndrome as a potential complication of dapsone use.
  • Early diagnosis and dapsone discontinuation are vital for managing this potentially fatal condition.
  • This case highlights the importance of monitoring patients for adverse drug reactions.